The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders
- PMID:33774758
- DOI: 10.1007/s12031-021-01825-7
The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders
Erratum in
- Correction to: The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.Juvale IIA, Che Has AT.Juvale IIA, et al.J Mol Neurosci. 2021 Jul;71(7):1356. doi: 10.1007/s12031-021-01854-2.J Mol Neurosci. 2021.PMID:33993453No abstract available.
Abstract
Neurodevelopmental disorders are defined as a set of abnormal brain developmental conditions marked by the early childhood onset of cognitive, behavioral, and functional deficits leading to memory and learning problems, emotional instability, and impulsivity. Autism spectrum disorder, attention-deficit/hyperactivity disorder, Tourette syndrome, fragile X syndrome, and Down's syndrome are a few known examples of neurodevelopmental disorders. Although they are relatively common in both developed and developing countries, very little is currently known about their underlying molecular mechanisms. Both genetic and environmental factors are known to increase the risk of neurodevelopmental disorders. Current diagnostic and screening tests for neurodevelopmental disorders are not reliable; hence, individuals with neurodevelopmental disorders are often diagnosed in the later stages. This negatively affects their prognosis and quality of life, prompting the need for a better diagnostic biomarker. Recent studies on microRNAs and their altered regulation in diseases have shed some light on the possible role they could play in the development of the central nervous system. This review attempts to elucidate our current understanding of the role that microRNAs play in neurodevelopmental disorders with the hope of utilizing them as potential biomarkers in the future.
Keywords: Attention-deficit/hyperactivity disorder; Autism spectrum disorder; Down’s syndrome; Fragile X syndrome; MicroRNA; Tourette syndrome.
Similar articles
- Treatment of Neurogenetic Developmental Conditions: From 2016 into the Future.van Karnebeek CD, Bowden K, Berry-Kravis E.van Karnebeek CD, et al.Pediatr Neurol. 2016 Dec;65:1-13. doi: 10.1016/j.pediatrneurol.2016.07.010. Epub 2016 Jul 26.Pediatr Neurol. 2016.PMID:27697313Review.
- Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders.Jokiranta-Olkoniemi E, Cheslack-Postava K, Sucksdorff D, Suominen A, Gyllenberg D, Chudal R, Leivonen S, Gissler M, Brown AS, Sourander A.Jokiranta-Olkoniemi E, et al.JAMA Psychiatry. 2016 Jun 1;73(6):622-9. doi: 10.1001/jamapsychiatry.2016.0495.JAMA Psychiatry. 2016.PMID:27145529
- Sex differences in neurodevelopmental disorders.May T, Adesina I, McGillivray J, Rinehart NJ.May T, et al.Curr Opin Neurol. 2019 Aug;32(4):622-626. doi: 10.1097/WCO.0000000000000714.Curr Opin Neurol. 2019.PMID:31135460Review.
- Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders.Khoodoruth MAS, Khoodoruth WNC, Uroos M, Al-Abdulla M, Khan YS, Mohammad F.Khoodoruth MAS, et al.Neurobiol Dis. 2024 Nov;202:106717. doi: 10.1016/j.nbd.2024.106717. Epub 2024 Oct 24.Neurobiol Dis. 2024.PMID:39461569Review.
- Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina.Sehovic E, Spahic L, Smajlovic-Skenderagic L, Pistoljevic N, Dzanko E, Hajdarpasic A.Sehovic E, et al.PLoS One. 2020 Apr 30;15(4):e0232351. doi: 10.1371/journal.pone.0232351. eCollection 2020.PLoS One. 2020.PMID:32353026Free PMC article.
Cited by
- MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder.Martinez B, Peplow PV.Martinez B, et al.Neural Regen Res. 2024 Mar;19(3):557-562. doi: 10.4103/1673-5374.380880.Neural Regen Res. 2024.PMID:37721284Free PMC article.Review.
- The Exon Junction Complex Factor RBM8A in Glial Fibrillary Acid Protein-Expressing Astrocytes Modulates Locomotion Behaviors.Asthana S, Mott J, Tong M, Pei Z, Mao Y.Asthana S, et al.Cells. 2024 Mar 13;13(6):498. doi: 10.3390/cells13060498.Cells. 2024.PMID:38534343Free PMC article.
- Zebrafish as an Emerging Model for Sarcopenia: Considerations, Current Insights, and Future Directions.Callegari S, Mirzaei F, Agbaria L, Shariff S, Kantawala B, Moronge D, Ogendi BMO.Callegari S, et al.Int J Mol Sci. 2023 Nov 30;24(23):17018. doi: 10.3390/ijms242317018.Int J Mol Sci. 2023.PMID:38069340Free PMC article.Review.
- MicroRNAs serve as prediction and treatment-response biomarkers of attention-deficit/hyperactivity disorder and promote the differentiation of neuronal cells by repressing the apoptosis pathway.Wang LJ, Kuo HC, Lee SY, Huang LH, Lin Y, Lin PH, Li SC.Wang LJ, et al.Transl Psychiatry. 2022 Feb 19;12(1):67. doi: 10.1038/s41398-022-01832-1.Transl Psychiatry. 2022.PMID:35184133Free PMC article.
- Liquid Biopsy in Adverse Neurodevelopment of Children: Problems and Prospects.Pu Y, An J, Mo X.Pu Y, et al.Methods Mol Biol. 2023;2695:337-349. doi: 10.1007/978-1-0716-3346-5_23.Methods Mol Biol. 2023.PMID:37450130Review.
References
- Abelson J, Kwan K, O’Roak B, Baek D, Stillman A, Morgan T, Mathews C, Pauls D, Rasin M, Gunel M, Davis N, Ercan-Sencicek A, Guez D, Spertus J, Leckman J, Dure L, Kurlan R, Singer H, Gilbert D, Farhi A, Louvi A, Lifton R, Sestan N, State M (2005) Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 310(5746):317–320 - PubMed
- Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS (2008) Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9:153–161 - PubMed
- Adams CM, Hiebert SW, Eischen CM (2016) Myc induces miRNA-mediated apoptosis in response to HDAC inhibition in hematologic malignancies. Can Res 76(3):736–748
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources